US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
Charlotte Observer14d
Frost & Sullivan Report Highlights SMX’s Cutting-Edge Protection for Cyber Hardware and Electronics Empowering AI
At the forefront of these efforts is its recently launched proprietary hardware protection technology, specifically designed to safeguard the critical hardware essential for the Artificial ...
Cure Today15d
FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS
GRAFAPEX™ (treosulfan) with fludarabine is FDA-approved for AML and MDS patients undergoing alloHSCT, showing improved overall survival compared to busulfan. Common side effects include ...
Rolling Out15d
FDA unveils 8 critical safety measures for berry industry
The Food and Drug Administration (FDA) has initiated sweeping changes ... Consumers gain additional protection through improved tracking and testing requirements. Health departments anticipate ...
Pharmaceutical Technology16d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS ... after concluding that the company artificially extended the therapy’s patent protection and ...
The Verge16d
The Galaxy S25 Edge is Samsung’s rumored ‘slim’ phone
He has written news, reviews, and more as a tech journalist since 2020. Samsung just teased the Galaxy S25 Edge at the end of its Unpacked event, where it announced its Galaxy S25 lineup.
healthday16d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Spravato is the first and only approved monotherapy for adults with refractory major depressive disorder. Approval of Spravato, granted following FDA priority review, was based on the results of a ...
The Hill16d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...
Newsweek16d
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...
CNN17d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
The New York Times17d
Trump Administration Cancels Flights for Refugees Already Approved for Travel
The decision leaves refugees who have completed a lengthy process stranded abroad and facing extended separation from loved ones already in the U.S. By Miriam Jordan and Hamed Aleaziz Miriam ...
Gizmodo17d
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
J&J announced the FDA’s supplemental approval Tuesday. Previously, Spravato was approved as an add-on therapy for treatment-resistant depression, in conjunction with an oral antidepressant.